journal article·2025-08

Confinement Suppresses Mechanical Force‐Mediated Cancer Cell Apoptosis

Alka Kumari, Akshay Kumar, Gao Xu, Kaustav Roy, Rudra Pratap, Andrew Holle, Ajay Tijore

Small· Volume 21· Issue 34
Publisher page

Abstract

Abstract During the invasion, cancer cells migrate through ‘3D channel‐like tracks’ present in the tissues' interstitial extracellular matrix (ECM). Cancer cell migration through these 3D confined channels leads to confinement‐induced cell deformation. Emerging reports show that cancer cells are susceptible to mechanical stretch/ultrasound (US)‐mediated mechanical forces and undergo calcium‐dependent apoptosis (mechanoptosis) under conditions that promote normal cell growth. Surprisingly, we find that confinement‐induced cell deformation suppresses mechanoptosis. Studies done using microchannel platforms and tumor spheroid models show that a low level of apoptosis is observed in confined cells. Further, apoptosis level is found to increase with a decrease in the degree of confinement. The absence of mature focal adhesions (FAs), low myosin IIA contractility, and diffuse mechanosensitive Piezo1 channels are responsible for a low level of apoptosis in confined cells. Thus, these findings suggest that confined cells, due to the absence of mature FAs, could not sense and transduce the mechanical forces and generate enough myosin IIA contractility required to initiate apoptosis. The combined action of US and activators of myosin contractility can be used to target invading cancer cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cellular Mechanics and Interactions · Erythrocyte Function and Pathophysiology · Microfluidic and Bio-sensing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering Indian Institute of Science Bangalore 560012 India

Centre for Nanoscience and Engineering Indian Institute of Science Bangalore 560012 India

Mechanobiology Institute National University of Singapore Singapore 117411 Singapore

Plaksha University Mohali 140306 India

Department of Biomedical Engineering National University of Singapore Singapore 117583 Singapore

Funding

Department of Biotechnology, Government of West Bengal · National Research Foundation Singapore

References (57)

Show source-provided references
1. 10.1038/8912610.1038/89126 ↗
2. 10.1242/jcs.05072410.1242/jcs.050724 ↗
3. 10.1007/s00418-008-0529-110.1007/s00418-008-0529-1 ↗
4. 10.4161/intv.2122310.4161/intv.21223 ↗
5. 10.1038/ncb165810.1038/ncb1658 ↗
6. 10.4161/intv.2529410.4161/intv.25294 ↗
7. 10.1016/j.cell.2011.11.01610.1016/j.cell.2011.11.016 ↗
8. 10.1016/j.semcdb.2009.08.00510.1016/j.semcdb.2009.08.005 ↗
9. Kumari A. · ACS Omega · 2023 · 8
10. 10.1096/fj.12-21144110.1096/fj.12-211441 ↗
11. 10.1039/c3ib20196a10.1039/c3ib20196a ↗
12. 10.1073/pnas.111807310910.1073/pnas.1118073109 ↗
13. 10.1152/ajpcell.00225.201410.1152/ajpcell.00225.2014 ↗
14. 10.1038/ncb206210.1038/ncb2062 ↗
15. 10.1021/acs.nanolett.4c0585810.1021/acs.nanolett.4c05858 ↗
16. 10.1002/btm2.1073710.1002/btm2.10737 ↗
17. 10.1038/s41598-018-26198-710.1038/s41598-018-26198-7 ↗
18. 10.1016/j.biomaterials.2021.12086610.1016/j.biomaterials.2021.120866 ↗
19. 10.1038/srep3997510.1038/srep39975 ↗
20. 10.1016/0301-5629(93)90020-O10.1016/0301-5629(93)90020-O ↗
21. 10.1002/btm2.1023310.1002/btm2.10233 ↗
22. 10.1590/s1677-5538.ibju.2018.03.0310.1590/s1677-5538.ibju.2018.03.03 ↗
23. 10.1007/BF0124014610.1007/BF01240146 ↗
24. 10.1530/ERC-17-004510.1530/ERC-17-0045 ↗
25. Lin C. Y. · Int. J. Nanomed. · 2012 · 7 · 1491
26. 10.1083/jcb.20190205710.1083/jcb.201902057 ↗
27. 10.1038/nature0890810.1038/nature08908 ↗
28. 10.1073/pnas.050025410210.1073/pnas.0500254102 ↗
29. 10.1038/nrm390310.1038/nrm3903 ↗
30. Liu Y. J. · Cell · 2015 · 160 · 634
31. 10.1038/s41563-021-01087-z10.1038/s41563-021-01087-z ↗
32. 10.1242/jcs.113.20.367310.1242/jcs.113.20.3673 ↗
33. 10.1038/3504665910.1038/35046659 ↗
34. 10.1088/1367-2630/15/1/01500310.1088/1367-2630/15/1/015003 ↗
35. Pan B. · Oncol. Lett. · 2018 · 15 · 4037
36. 10.1083/jcb.146.6.137510.1083/jcb.146.6.1375 ↗
37. 10.1038/s42003-019-0514-310.1038/s42003-019-0514-3 ↗
38. 10.1126/sciadv.abo146110.1126/sciadv.abo1461 ↗
39. 10.1038/s41556-020-0552-610.1038/s41556-020-0552-6 ↗
40. 10.1186/s12935-021-01898-910.1186/s12935-021-01898-9 ↗
41. 10.26508/lsa.20240260110.26508/lsa.202402601 ↗
42. 10.1038/nature1081210.1038/nature10812 ↗
43. 10.1007/s10120-021-01239-910.1007/s10120-021-01239-9 ↗
44. 10.1038/s41568-018-0038-z10.1038/s41568-018-0038-z ↗
45. 10.3389/fphar.2022.95559510.3389/fphar.2022.955595 ↗
46. 10.1021/nn400202j10.1021/nn400202j ↗
47. 10.1038/s41551-017-0127-410.1038/s41551-017-0127-4 ↗
48. 10.1073/pnas.111988610910.1073/pnas.1119886109 ↗
49. 10.1016/S0092-8674(04)00058-310.1016/S0092-8674(04)00058-3 ↗
50. 10.1016/j.tcb.2006.02.00510.1016/j.tcb.2006.02.005 ↗
51. 10.1038/ncb327710.1038/ncb3277 ↗
52. 10.1021/acsnano.0c0313010.1021/acsnano.0c03130 ↗
53. 10.1021/acsnano.4c0210410.1021/acsnano.4c02104 ↗
54. 10.1002/advs.20230222810.1002/advs.202302228 ↗
55. 10.1126/sciadv.aba650510.1126/sciadv.aba6505 ↗
56. 10.1002/advs.20240161110.1002/advs.202401611 ↗
57. Kingsler L. E. · 2000